DFSVX | LFVCX | DFSVX / LFVCX | |
Total Expense Ratio | 0.31 | 2.03 | 15% |
Annual Report Gross Expense Ratio | 0.31 | 2.10 | 15% |
Fund Existence | 32 years | 6 years | - |
Gain YTD | 0.901 | -2.999 | -30% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16B | 91.4M | 17,505% |
Annual Yield % from dividends | 1.67 | 0.00 | - |
Returns for 1 year | 0.60 | -8.18 | -7% |
Returns for 3 years | 27.09 | 9.52 | 284% |
Returns for 5 years | 94.25 | 43.48 | 217% |
Returns for 10 years | 50.73 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HAGIX | 83.44 | 0.75 | +0.91% |
Carillon Eagle Mid Cap Growth I | |||
VYMRX | 16.91 | 0.14 | +0.83% |
Voya Mid Cap Research Enhanced Index C | |||
GLCCX | 21.93 | 0.13 | +0.60% |
Goldman Sachs Large Cap Gr Insghts C | |||
GMXPX | 24.48 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts P | |||
LHCOX | 18.64 | 0.05 | +0.27% |
Lord Abbett Health Care F3 |